Myovant Sciences Ltd.
SEC CIK 1679082 · MYOV · last insider filing 2023-03-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Potter Myrtle S | Director | filed 2018 - 2023 |
| Guinan Mark | Director | filed 2018 - 2023 |
| Marek David C | Director · Principal Executive Officer | filed 2021 - 2023 |
| Gulfo Adele M. | Director | filed 2019 - 2023 |
| Curran Terrie | Director | filed 2016 - 2023 |
| Valente Nancy | Director | filed 2021 - 2023 |
| Nishinaka Shigeyuki | Director | filed 2022 - 2022 |
| Sebelius Kathleen | Director | filed 2016 - 2020 |
| Seely Lynn | Director · Principal Executive Officer | filed 2016 - 2020 |
| Nomura Hiroshi | Director | filed 2019 - 2019 |
| Torti Frank | Director | filed 2018 - 2019 |
| QVT Associates GP LLC | Director | filed 2016 - 2019 |
| QVT Fund V LP | Director | filed 2016 - 2019 |
| Altmeyer Mark | Director | filed 2016 - 2018 |
| Deveydt Wayne S | Director | filed 2016 - 2017 |
| Manchester Keith S | Director | filed 2016 - 2016 |
| Ramaswamy Vivek | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lang Matthew | General Counsel & Corp. Secy. | filed 2017 - 2023 |
| Ferreira Juan Camilo Arjona | Chief Medical Officer | filed 2017 - 2023 |
| Merendino Lauren | Chief Commercial Officer | filed 2021 - 2023 |
| Mehra Uneek | Principal Financial Officer | filed 2021 - 2023 |
| Karbe Frank | Principal Fin'l & Accounting | filed 2016 - 2021 |
| Sablich Kim | Chief Commercial Officer | filed 2018 - 2020 |
| Romeo Marianne L. | Head,Global Trans. & Risk Mgmt | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.